Related Experiment Video

Updated: Dec 9, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020

Giovanni Battista Migliori, Pei Min Thong, Onno Akkerman

    Emerging Infectious Diseases
    |September 12, 2020
    PubMed

    Insights

    Global tuberculosis services were disrupted by coronavirus disease (COVID-19). Tuberculosis center attendance decreased significantly in early 2020 compared to 2019, highlighting the need for continued tuberculosis care resources.

    Area of Science:

    • Global health
    • Infectious diseases
    • Public health

    Background:

    • The coronavirus disease (COVID-19) pandemic has significantly impacted healthcare systems worldwide.
    • Disruptions to essential health services, including tuberculosis (TB) care, have been reported globally.
    • Maintaining continuity of care for chronic diseases like TB is crucial during global health crises.

    Purpose of the Study:

    • To assess the impact of the COVID-19 pandemic on tuberculosis service utilization.
    • To quantify changes in tuberculosis center attendance during the initial phase of the pandemic.
    • To highlight the need for resources to ensure tuberculosis care continuity.

    Main Methods:

    • Data collected from 33 tuberculosis centers across 16 countries on 5 continents.
    • Comparative analysis of tuberculosis center attendance during January-April 2020 versus January-April 2019.
    • Retrospective data review.

    Main Results:

    • A notable decrease in attendance at tuberculosis centers was observed during the first 4 months of 2020 compared to the same period in 2019.
    • This decline suggests a significant disruption to routine tuberculosis services.
    • The impact was observed across multiple countries and continents.

    Conclusions:

    • The COVID-19 pandemic has severely disrupted global tuberculosis services.
    • Urgent allocation of resources is required to maintain tuberculosis care and prevent setbacks in TB control efforts.
    • Ensuring the continuity of essential services like tuberculosis treatment is paramount during pandemics.

    Keywords:
    2019 novel coronavirus diseaseCOVID-19SARS-CoV-2TBcoronavirus diseasehealth servicesrespiratory infectionssevere acute respiratory syndrome coronavirus 2tuberculosis and other mycobacteriaviruseszoonoses

    More Related Videos

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    19.1K
    Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis06:26

    Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

    Published on: July 28, 2023

    2.8K

    Related Concept Videos

    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
    375
    Pulmonary Tuberculosis I01:29

    Pulmonary Tuberculosis I

    Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
    Causative Organism
    The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
    Mode of...
    623
    Pulmonary Tuberculosis II01:28

    Pulmonary Tuberculosis II

    Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
    Here is a detailed explanation of its pathophysiology:
    Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
    1.1K
    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    330
    Pulmonary Tuberculosis III01:31

    Pulmonary Tuberculosis III

    Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
    The first classification is based on the development of the disease, and it includes the following categories:
    699
    Other Pulmonary Disorders01:17

    Other Pulmonary Disorders

    Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
    1.4K